Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,472.35
(
0.65%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
105.61
(
-0.15%
)
Bitcoin
80,632.01
(
0.18%
)
News Focus
News Focus
Post# of 6105
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 51
Posts 5534
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 5928

Tuesday, 02/10/2026 9:03:14 PM

Tuesday, February 10, 2026 9:03:14 PM

Post# of 6105
GILD earnings this pm show quite the contrast.
US HCV sales decreased in Q4 from 185M to 140 YoY

https://www.gilead.com/news/news-details/2026/gilead-sciences-announces-fourth-quarter-and-full-year-2025-financial-results

ABBV niche approval in acute pts is having a real impact on sales in the chronic patient indication
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENTA News
More ENTA News